RGEN
REPLIGEN CORP
Next earnings Jul 27, 2026 (before open) · consensus $0.46 EPS, $206M rev
Last earnings +6.3% on 2026-05-05
$138.40
▲ +9.52%$138.40▲ +17.75%
over 1Y
L $102.87EODHDH $172.26
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.5%
1W+3.6%
1M+20.1%
3M+21.1%
YTD-15.8%
1Y+17.7%
Hold
Conviction
Horizon
Long (>12mo)
Street · 28 analysts
Buy
High-quality bioprocessing-tools franchise recovering from destocking, but 153x earnings and 10x sales price in a full rebound already.
The read
Sources: SEC EDGAR (CIK 0000730272, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/21/2026, 8:52:40 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.